NAAA
ABBV icon

New Age Alpha Advisors’s AbbVie ABBV Stock Holding History

New Age Alpha Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
+10,167
New +$2.19M 0.11% 243
2025
Q4 		– Sell
-151
Closed -$35K – 762
2025
Q3 		$35K Hold
151
– – ﹤0.01% 764
2025
Q2 		$28K Hold
151
– – ﹤0.01% 790
2025
Q1 		$31.6K Buy
151
+18
+14% +$3.5K ﹤0.01% 848
2024
Q4 		$23.6K Buy
133
+51
+62% +$9.38K ﹤0.01% 843
2024
Q3 		$16.2K Buy
+82
New +$15.3K 0.01% 136

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

New Age Alpha Advisors's ABBV Position: Q2 2026 in Review

New Age Alpha Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 10,167 shares worth $2.56M. The stake represents 0.11% of the portfolio and ranks #243 among its holdings. This is a return to the name: New Age Alpha Advisors previously reported a position in ABBV as recently as Q3 2025.

New Age Alpha Advisors first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New Age Alpha Advisors held 10,167 shares of AbbVie worth $2.56M as of Q2 2026.
  • AbbVie was a new New Age Alpha Advisors position in Q2 2026.
  • AbbVie made up 0.11% of New Age Alpha Advisors's portfolio in Q2 2026, its #243 holding.
  • New Age Alpha Advisors first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.